10-Q: Superior Group of Companies Reports Strong First Quarter 2024 Results, Driven by Sales and Margin Growth

Superior Group of Companies saw a significant increase in net income for the first quarter of 2024, driven by sales growth and improved gross margins across all segments.

Summary

• Superior Group of Companies reported a net income of $3.9 million for the three months ended March 31, 2024, compared to $0.9 million for the same period in 2023.
• The company's net sales increased by 6.2% to $138.8 million, up from $130.8 million in the prior year.
• Gross margin improved to 39.8% in Q1 2024 from 36.0% in Q1 2023, driven by improvements in all three segments.
• EBITDA for the quarter was $9.6 million, compared to $6.9 million in the same period last year.
• The company's Branded Products segment saw a 6.4% increase in net sales, while Healthcare Apparel and Contact Centers segments also experienced growth.
• Selling and administrative expenses increased to 35.1% of net sales, up from 33.2% in the prior year, due to increased employee costs and changes in fair value of written put options and acquisition contingent liabilities.
• Interest expense decreased to $1.8 million from $2.6 million due to a reduction in outstanding borrowings.
• The company's effective tax rate was 14.8% for the quarter, compared to 6.0% in the prior year, impacted by the mix of earnings across foreign and domestic operations and windfall benefits from stock option exercises.
• The company had $22.0 million in cash and cash equivalents as of March 31, 2024, and working capital of $179.4 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and growth across all segments. While there are some risks and challenges, the overall tone is optimistic and indicates a well-performing company.

Positives

• The company experienced strong growth in net income, sales, and gross margins across all segments.
• EBITDA saw a significant increase, indicating improved operational performance.
• The Branded Products segment showed strong sales growth, driven by higher order volume and increased pricing.
• The Healthcare Apparel segment benefited from increased online sales and improved manufacturing efficiencies.
• The Contact Centers segment continued to grow, driven by existing customer demand.
• Interest expense decreased due to lower outstanding borrowings.
• The company remains in compliance with its debt covenants.

Negatives

• Selling and administrative expenses increased as a percentage of net sales, driven by higher employee costs and changes in fair value of written put options and acquisition contingent liabilities.
• The effective tax rate increased to 14.8% due to the mix of earnings across foreign and domestic operations and windfall benefits from stock option exercises.
• Cash flow from operating activities decreased compared to the prior year, primarily due to changes in working capital.

Risks

• The company faces risks related to competition, supply disruptions, inflation, and general economic and political conditions.
• Civil unrest in countries where the company manufactures products, such as Haiti, could disrupt operations.
• The company has a material weakness in internal control over financial reporting related to certain proprietary information technology systems of the Contact Centers segment.
• The company is subject to market risk exposure related to changes in interest rates on its debt.
• Sales to customers outside of the United States are subject to fluctuations in foreign currency exchange rates.

Future Outlook

The company anticipates that it will continue to pay dividends in the future as financial conditions permit and expects to spend more on capital expenditures in 2024 than in 2023. Management believes that the combination of current cash levels, cash flows from operating activities, and availability under the revolving credit facility will be sufficient to satisfy the company's requirements for the next twelve months.

Management Comments

• Management believes that synergies within the Branded Products segment will create opportunities to cross-sell products to new and existing customers.
• Management expects that demand for the company's signature marketing brands in the Healthcare Apparel segment will continue to provide opportunities for growth and increased market share.
• Management believes The Office Gurus is positioned well to continue growing the Contact Centers business.

Industry Context

The company operates in the branded products, healthcare apparel, and contact center industries. The report indicates that the company is experiencing growth in all three segments, which suggests a positive trend in the markets it serves. The nearshore call-center market is growing as businesses look to reduce operating costs while maintaining high-quality customer support.

Comparison to Industry Standards

• The company's gross margin of 39.8% is a positive result, indicating strong pricing power and cost management compared to industry averages.
• The company's EBITDA growth of 39% year-over-year suggests strong operational performance compared to peers.
• The company's debt levels and leverage ratios are within acceptable limits, indicating a healthy financial position compared to industry benchmarks.
• Comparable companies in the branded products space include promotional product distributors and uniform suppliers, while healthcare apparel competitors include medical uniform manufacturers and distributors. Contact center competitors include other BPO providers.
• The company's performance in the first quarter of 2024 is a positive sign, indicating that it is well-positioned to compete in its respective industries.

Legal Proceedings

• The company is involved in various legal actions and claims arising from the normal course of business, but management does not expect these to have a material impact on the company's results.

Stakeholder Impact

• Shareholders will benefit from the improved financial performance and continued dividend payments.
• Employees may benefit from the company's growth and success.
• Customers will continue to receive products and services from the company.
• Suppliers will continue to have business relationships with the company.
• Creditors will be reassured by the company's strong financial position.

Next Steps

• The company will continue to evaluate the Guardian liability for remeasurement at the end of each reporting period.
• The company will monitor the effectiveness of its remediation plan for the material weakness in internal control over financial reporting.
• The company will continue to pay dividends as financial conditions permit.
• The company will continue to evaluate its capital expenditure program in light of prevailing economic conditions.

Key Dates

Keywords

financial results, net income, net sales, gross margin, EBITDA, branded products, healthcare apparel, contact centers, operating segments, share-based compensation, debt, liquidity, internal control, performance shares